Literature DB >> 23781756

Hemophagocytic syndrome with hyperferritinemia: a stormy immunological response.

Gisele Zandman-Goddard, Yehuda Shoenfeld.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23781756

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  5 in total

1.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

2.  H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.

Authors:  P Ruscitti; P Cipriani; F Ciccia; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; G Guggino; S Di Bartolomeo; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

Review 3.  The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.

Authors:  Cristina Rosário; Gisele Zandman-Goddard; Esther G Meyron-Holtz; David P D'Cruz; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-08-22       Impact factor: 8.775

4.  Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.

Authors:  Piero Ruscitti; Paola Di Benedetto; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Anna Rita Lizzi; Paola Cipriani; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

5.  Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning.

Authors:  Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2020-04-05       Impact factor: 9.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.